AtriCure Inc. (NASDAQ:ATRC) reported its Q4 2024 earnings, revealing a wider-than-expected loss per share but exceeding revenue forecasts. The company's stock fell in aftermarket trading following the ...
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) ...
Corporation (market cap: $2.7 billion) reported its fourth-quarter 2024 earnings, surpassing Wall Street expectations with an EPS of $0.63 against the forecasted $0.58. Revenue also exceeded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback